Xu Sheng, Nie Jingya, Zeng Wenjie, Lai Yucheng, Chen Xiaoyan, Yu Yan
Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Department of Gynecology, Nanxun People's Hospital of Huzhou, Affiliated Zhejiang Provincial People's Hospital Branch, Huzhou, China.
Wideochir Inne Tech Maloinwazyjne. 2023 Dec;18(4):690-697. doi: 10.5114/wiitm.2023.133777. Epub 2023 Dec 13.
Pelvic organ prolapse (POP), a common and benign condition, is characterized by the descent of one or more aspects of the vagina and uterus. A wide variety of mesh-based surgical techniques have been proved to be effective in the treatment of pelvic organ prolapse (POP).
To evaluate the efficacy of a modified laparoscopic lateral suspension with mesh (mLLSM) in patients with apical and anterior pelvic organ prolapse.
All patients diagnosed with apical and anterior pelvic organ prolapse underwent a modified laparoscopic lateral suspension with mesh (mLLSM). Perioperative parameters including surgical time, blood loss and complications were recorded. At the minimal 12-month follow-up, primary outcome measures included both anatomical and functional points. The anatomical cure rate was evaluated using the Pelvic Organ Prolapse Questionnaire (POP-Q) assessment. Patient satisfaction was evaluated using questionnaires.
Mean surgical time was 91.56 ±15.33 min; mean estimated blood loss was 55.42 ±36.73 ml; no intraoperative complications were noted in the perioperative period. After a minimal 12-month follow-up period, rates of anatomical success and subjective satisfaction were 96.33% and 94.50%, respectively. Symptom severity and quality of life also improved significantly.
We found mLLSM to be a safe and effective treatment for patients suffering apical and anterior pelvic organ prolapse. We found mLLSM to result in excellent outcomes and fewer mesh complications, underscoring its potential as an alternative treatment option for the management of apical and anterior pelvic organ prolapse.
盆腔器官脱垂（POP）是一种常见的良性病症，其特征为阴道和子宫的一个或多个部位下降。多种基于补片的手术技术已被证明在治疗盆腔器官脱垂（POP）方面有效。
评估改良腹腔镜补片侧方悬吊术（mLLSM）治疗顶端和前部盆腔器官脱垂患者的疗效。
所有诊断为顶端和前部盆腔器官脱垂的患者均接受改良腹腔镜补片侧方悬吊术（mLLSM）。记录围手术期参数，包括手术时间、失血量和并发症。在至少12个月的随访中，主要结局指标包括解剖学和功能指标。使用盆腔器官脱垂问卷（POP-Q）评估解剖学治愈率。通过问卷调查评估患者满意度。
平均手术时间为91.56±15.33分钟；平均估计失血量为55.42±36.73毫升；围手术期未发现术中并发症。经过至少12个月的随访期后，解剖学成功率和主观满意度分别为96.33%和94.50%。症状严重程度和生活质量也有显著改善。
我们发现改良腹腔镜补片侧方悬吊术（mLLSM）是治疗顶端和前部盆腔器官脱垂患者的一种安全有效的方法。我们发现改良腹腔镜补片侧方悬吊术（mLLSM）可产生优异的治疗效果且补片并发症较少，这突出了其作为顶端和前部盆腔器官脱垂治疗替代方案的潜力。
